Spruce Biosciences Inc. (SPRB)
NASDAQ: SPRB
· Real-Time Price · USD
0.06
-0.01 (-8.95%)
At close: Jun 05, 2025, 3:12 PM
0.06
0.00%
After-hours: Jun 05, 2025, 03:12 PM EDT
-8.95% (1D)
| Bid | 0.06 |
| Market Cap | 2.56M |
| Revenue (ttm) | 2.91M |
| Net Income (ttm) | -41.41M |
| EPS (ttm) | -1.33 |
| PE Ratio (ttm) | -0.05 |
| Forward PE | -0.1 |
| Analyst | Hold |
| Ask | 0.07 |
| Volume | 24,831 |
| Avg. Volume (20D) | 1,389,892 |
| Open | 0.06 |
| Previous Close | 0.07 |
| Day's Range | 0.06 - 0.07 |
| 52-Week Range | 0.06 - 0.71 |
| Beta | 2.50 |
About SPRB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SPRB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SPRB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-39.14%
Spruce Biosciences shares are trading lower after ...
Unlock content with
Pro Subscription
1 month ago
-58.02%
Spruce Biosciences shares are trading lower. The company announced a new corporate strategy and acquisition of tralesinidase alfa enzyme replacement therapy for the treatment of Sanfilippo Syndrome Type B.
